Tobias Geisler

Interventional cardiologist / Cardiologist
Department of Cardiology and Angiology, University Hospital Tuebingen - Tuebingen, Germany

Latest contributions

More possibilities in TEER - Treatment of degenerative mitral regurgitation

09 Feb 2025 – From PCR Tokyo Valves 2025

Through case reviews, explore the latest advancements in transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation. Discover how a novel TEER device expands treatment possibilities, offering predictable and durable results.

More possibilities in TEER - Treatment of degenerative mitral regurgitation

Mitral valve interventions cases

09 Feb 2025 – From PCR Tokyo Valves 2025

This session delves into the latest advancements in minimally invasive mitral valve interventions. Explore a range of cutting-edge techniques, including 4D intracardiac echocardiography-guided mitral valve-in-valve procedures, valve-in-ring for severe mitral stenosis, pre-emptive tip to base LAMPOON in valve-in-ring TMVR, and chordal mapping with live multi-planar reconstruction...

Mitral valve interventions cases

M-TEER around the world

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest insights and advancements in the field of Mitral Transcatheter Edge-to-Edge Repair (M-TEER) from around the world. Discover a new anatomical risk score for predicting procedural outcomes, two-year outcomes from the MiCLASP study, the impact of regurgitant volume to left atrial volume ratio on...

M-TEER around the world

Tips and tricks for M-TEER

08 Feb 2025 – From PCR Tokyo Valves 2025

Discover valuable tips and tricks for Mitral Transcatheter Edge-to-Edge Repair (M-TEER) in this session. Learn about navigating difficult transseptal access through a left-atrial septal pouch, managing severe mitral regurgitation in an octogenarian with scoliosis and kyphosis, and innovative techniques like diamond-shape clasping using the PASCAL device....

Tips and tricks for M-TEER

M-TEER for secondary mitral regurgitation

08 Feb 2025 – From PCR Tokyo Valves 2025

Managing secondary mitral regurgitation with M-TEER requires a tailored approach. This PCR Tokyo Valves 2025 session explores key considerations for atrial functional MR and VFMR beyond COAPT criteria, helping you refine patient selection, procedural strategies, and post-treatment management through expert insights and real-world cases.

M-TEER for secondary mitral regurgitation

Impact of late-breaking clinical evidence on your daily mitral TEER practice

25 Nov 2024 – From PCR London Valves 2024

In this roundtable discussion, Tobias Geisler, Maurizio Taramasso, and Robert Smith delve into the late-breaking trials presented at PCR London Valves 2024. They examine the CLASP IID study, which compares TEER devices for severe mitral regurgitation, and the MiCLASP study, evaluating edge-to-edge therapy approaches. Together, they...

Impact of late-breaking clinical evidence on your daily mitral TEER practice

Clinical management before and after transcatheter tricuspid valve intervention

25 Nov 2024 – From PCR London Valves 2024

Looking to refine your approach to managing patients undergoing transcatheter tricuspid valve intervention? This video is for you!

You'll learn how to optimize patient preparation, master pathways for effective medical management before, during and after the procedure, and tackle specific post-procedural complications such as thrombosis, conduction disturbances...

Clinical management before and after transcatheter tricuspid valve intervention

Insights from the top late-breaking trials at PCR London Valves 2024

24 Nov 2024 – From PCR London Valves 2024

Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.

Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...

Insights from the top late-breaking trials at PCR London Valves 2024

Treating diverse mitral regurgitation anatomies: the power of versatility

16 May 2023 – From EuroPCR 2023

Based on a LIVE mitral TEER educational procedure and several case examples, this MR patient session will allow you to learn more about the PASCAL platform and system, as well as the latest clinical and real-world data on mitral TEER using the PASCAL system, while benefiting...

Treating diverse mitral regurgitation anatomies: the power of versatility

The new PASCAL Precision system unleashes the full potential of mitral transcatheter edge-to-edge repair

28 Nov 2022 – From PCR London Valves 2022

Join this panel of experienced physicians to learn more about the novel PASCAL Precision system and to discuss implant selection and clinical data. Finally, participate in a recorded case demonstrating the use of the PASCAL Precision system for the treatment of mitral regurgitation.

2022: a tipping point in the treatment of mitral regurgitation patients

17 May 2022 – From EuroPCR 2022

With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.

2022: a tipping point in the treatment of mitral regurgitation patients

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

23 Nov 2021 – From PCR London Valves

Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

Controversies in antiplatelet therapy for secondary prevention of coronary artery events

26 Jun 2020 – From PCR e-Course

Watch this session if you want to understand more about the guidelines for antiplatelet secondary prevention of ACS/PC and to review available data on antiplatelet therapy after ACS/PCI.

Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events